• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压药物治疗。

Hypertension Drug Therapy.

机构信息

Chinese Academy of Medical Sciences FUWAI Hospital Hypertension Division, 167 Beilishilu West City District, 100037, Beijing People's Republic of China, China.

出版信息

Adv Exp Med Biol. 2020;1177:149-268. doi: 10.1007/978-981-15-2517-9_6.

DOI:10.1007/978-981-15-2517-9_6
PMID:32246447
Abstract

Hypertension is still the number one global killer. No matter what causes are, lowering blood pressure can significantly reduce cardiovascular complications, cardiovascular death, and total death. Unfortunately, some hypertensive individuals simply do not know having hypertension. Some knew it but either not being treated or treated but blood pressure does not achieve goal. The reasons for inadequate control of blood pressure are many. One important reason is that we are not very familiar with antihypertensive agents and less attention has been paid to comorbidities, complications as well as the hypertension-modified target organ damage in patients with hypertension. The right antihypertensive drug was not given to the right hypertensive patients at right time. This reviewer studied comprehensively the literature, hopefully that the review will help improve antihypertensive drug selection and antihypertensive therapy.

摘要

高血压仍然是头号全球杀手。无论病因是什么,降低血压都能显著减少心血管并发症、心血管死亡和全因死亡。不幸的是,一些高血压患者根本不知道自己患有高血压。有些患者虽然知道,但要么未接受治疗,要么治疗后血压仍未达标。血压控制不佳的原因很多。一个重要原因是我们对降压药物并不十分熟悉,对高血压患者的合并症、并发症以及高血压引起的靶器官损害关注较少。没有在适当的时间将合适的降压药物给到合适的高血压患者。本综述者全面研究了文献,希望这篇综述有助于改善降压药物选择和降压治疗。

相似文献

1
Hypertension Drug Therapy.高血压药物治疗。
Adv Exp Med Biol. 2020;1177:149-268. doi: 10.1007/978-981-15-2517-9_6.
2
The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.血管紧张素II 1型受体拮抗剂在老年高血压患者中的作用。
Drugs Aging. 2006;23(2):131-55. doi: 10.2165/00002512-200623020-00004.
3
Goals of antihypertensive therapy.抗高血压治疗的目标。
Drugs. 1995 Feb;49(2):161-75. doi: 10.2165/00003495-199549020-00002.
4
Cochrane in context: pharmacological interventions for hypertension in children.Cochrane背景下:儿童高血压的药物干预
Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975.
5
Blood pressure variability: clinical implications and effects of antihypertensive treatment.血压变异性:临床意义及降压治疗的影响
J Hypertens Suppl. 1994 Jul;12(5):S35-40.
6
Pharmacological interventions for hypertension in children.儿童高血压的药物干预措施。
Evid Based Child Health. 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974.
7
Statins in hypertension: are they a new class of antihypertensive agents?他汀类药物在高血压中的应用:它们是一类新型的抗高血压药物吗?
Am J Ther. 2010 May-Jun;17(3):255-62. doi: 10.1097/MJT.0b013e3181c0695e.
8
Treatment of Hypertension: Which Goal for Which Patient?高血压的治疗:针对不同患者应设定何种目标?
Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97.
9
[Retrospective studies and prospects of therapy for hypertension].[高血压治疗的回顾性研究与展望]
Herz. 1995 Dec;20(6):370-89.
10
Treatment goals in hypertension.高血压的治疗目标。
Am J Med. 1984 Feb 27;76(2A):1-3. doi: 10.1016/0002-9343(84)90951-3.

引用本文的文献

1
Analytical Interference in Chemiluminescence Assay-Measured Angiotensin I, Angiotensin II, Aldosterone, and Renin.化学发光分析法测定血管紧张素 I、血管紧张素 II、醛固酮和肾素的分析干扰。
J Clin Lab Anal. 2024 May;38(10):e25045. doi: 10.1002/jcla.25045. Epub 2024 Jun 1.
2
Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies.病前使用选择性β受体阻滞剂可改善脓毒症的发生率和病程:人类队列研究和动物模型研究
Front Med (Lausanne). 2023 Apr 18;10:1105894. doi: 10.3389/fmed.2023.1105894. eCollection 2023.
3
Editorial: Medicinal Plants in the Treatment of Myocardial Injury and Vascular Diseases.
社论:药用植物在心肌损伤和血管疾病治疗中的应用
Front Pharmacol. 2022 Apr 1;13:879557. doi: 10.3389/fphar.2022.879557. eCollection 2022.
4
Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment.药物微生物组学:在抗高血压治疗中利用药物与微生物群的相互作用
Front Med (Lausanne). 2022 Jan 19;8:742394. doi: 10.3389/fmed.2021.742394. eCollection 2021.
5
Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study.不同三联组合抗高血压药物对血压控制、代谢模式和事件发生率的长期影响:来自布里西盖拉心脏研究的数据。
J Clin Med. 2021 Dec 17;10(24):5921. doi: 10.3390/jcm10245921.